Articles tagged "Kidney transplantation"

2020 American Transplant Congress
Patient-Reported Outcomes in a Prospective Multicenter Trial of Belatacept-Based CNI- and Corticosteroid-Free Immunosuppression Regimens in Kidney Transplantation: A Prospective Analysis Across Two Years
J. M. Rohan¹, J. Leone², E. Woodle³, D. Kaufman⁴, A. Shields⁵, A. Wiseman⁶, A. Matas⁷, P. West-Thielke⁸, E. King⁵, R. Alloway³
¹Pediatrics, Children's Hospital of Richmond at Virginia Commonwealth University, Richmond, VA, ²Tampa General, Tampa, FL, ³University of Cincinnati, Cincinnati, OH, ⁴U Wisconsin, Madison, WI, ⁵U Cincinnati, Cincinnati, OH, ⁶U Colorado, Denver, CO, ⁷U Minnesota, Minneapolis, MN, ⁸UIC, Chicago, IL
*Purpose: Previous trials have not examined 2-year longitudinal differences in patient-reported outcomes (PRO) between belatacept (BELA)- and tacrolimus (TAC)-based therapies in adult kidney transplant (KTx)…
2020 American Transplant Congress
Kidney Paired Donation Outcomes among High PRA Recipients
A. Thomas¹, A. Shaffer², M. Henderson², D. Segev²
¹University of North Carolina, Chapel Hill, NC, ²Johns Hopkins, Baltimore, MD
*Purpose: Kidney paired donation (KPD) accounts for an increasing amount of living donor transplants in the US. Previous studies have shown equivalent outcomes between transplants…
2020 American Transplant Congress
Impact of Immunogenicity on Kidney Allograft Survival in Patients Treated with Induction Therapy
R. Michael, B. Mierzejewska, D. Bekbolsynov, J. Ortiz, O. Ekwenna, S. Stepkowski
University of Toledo, Toledo, OH
*Purpose: The induction therapy is currently used in the majority of kidney transplant recipients, regardless of their level of donor/recipient compatibility. We examined whether lower…
2020 American Transplant Congress
Discrepant Subtyping of Blood Type A2 Living Kidney Donors in Paired Kidney Exchange
L. Warnke¹, R. R. Redfield¹, K. M. Miller¹, M. Cooper², G. Roll³, C. Freise³, B. Lee³, V. Chipman³, A. Thomas⁴, D. Leeser⁵, M. Ronin⁶, G. Hil⁶, A. D. Waterman⁷, D. Mandelbrot¹
¹Transplant, UW Health, Madison, WI, ²Transplant, Medstar Georgetown, Washington, DC, ³Transplant, UCSF, San Fransisco, CA, ⁴Surgery, Johns Hopkins University, Baltimore, MD, ⁵Transplant, ECU, Greenville, NC, ⁶NKR, Babylon, NY, ⁷Nephrology, UCLA; Terasaki Research Institute, Los Angeles, CA
*Purpose: Utilizing non-A1 donors for O or B recipients with low anti-A titers presents an opportunity to expand living donor kidney transplantation. Since February 2018,…
2020 American Transplant Congress
Kidneys from AKI Donors with Poor Long-Term Outcomes Present an Impaired Protein Expression for Cellular Stress and Repair
F. Neri¹, M. Lo Faro¹, C. Boffa¹, T. Surik¹, M. Kaisar¹, E. J. Sharples², J. P. Hunter¹, J. Lindeman³, R. Ploeg¹
¹Nuffield Department of Surgical Sciences, Oxford University, Oxford, United Kingdom, ²Oxford Transplant Centre, Oxford, United Kingdom, ³Department of Vascular Surgery, Leiden University Medical Center (LUMC), Leiden, Netherlands
*Purpose: The utilization of kidneys from donors with acute kidney injury (AKI) is often limited by unpredictable post-transplantation outcomes. The aim of our study was…
2020 American Transplant Congress
Proposed New Kidney Allocation Policy: Moving to Concentric Circles as the First Unit of Allocation
A. Israni¹, S. Gustafson¹, A. Wey¹, B. Thompson¹, V. Casingal², M. Pavlakis³, S. Castro⁴, A. Wilk⁴, B. Kasiske¹, J. Snyder¹
¹SRTR, Minneapolis, MN, ²Carolinas Healthcare, Charlotte, NC, ³Beth Israel Deaconess, Boston, MA, ⁴UNOS, Richmond, VA
*Purpose: The Organ Procurement and Transplantation Network (OPTN) proposed a new national deceased donor kidney allocation policy that removes donor service area and OPTN region…
2020 American Transplant Congress
Infectious Complications and Malignancy after Kidney Transplantation in the Elderly Population
L. Liriano-Ward, M. Parides, Y. Al Azzi, C. Pynadath, M. Ajaimy, J. Graham, S. Greenstein, M. Kinkhabwala, J. Rocca, E. Akalin
Montefiore Medical Center, Bronx, NY
*Purpose: Kidney transplantation improves quality of life and survival in all patients regardless of age. However, older patients are prone to development of side effects…
2020 American Transplant Congress
Clinical Outcomes from a Mobile Health, Pharmacist-Led Intervention: 12-Month Results of the Transafe Rx Randomized Controlled Trial
D. Taber, J. Hirsch, Z. Su, J. McGillicuddy, A. Posadas, J. Fleming
Med Univ of South Carolina, Charleston, SC
*Purpose: Medication errors and non-adherence are predominant causes of poor graft outcomes in kidney transplant (KTX) recipients. The primary aim of the TRANSAFE Rx RCT…
2020 American Transplant Congress
Time for Change: Assessment of Renal Transplant Artery Stenosis with N.A.T.I.V.E. True-F.I.S.P. and N.A.T.I.V.E. G.R.E
J. C. Infante¹, A. Mattiazzi², M. Morsi³, G. Guerra², M. J. Defreitas⁴, J. Chandar⁴, L. J. Chen³, G. W. Burke³, J. Figueiro³, G. Ciancio³
¹Radiology, University of Miami, Miami, FL, ²Department of Medicine, Division of Nephrology, University of Miami / Miami Transplant Institute, Miami, FL, ³Department of Surgery, University of Miami / Miami Transplant Institute, Miami, FL, ⁴Department of Pediatrics, Division of Nephrology, University of Miami, Miami, FL
*Purpose: Non-contrast MRA can be fraught with artifact and lack of signal both in areas of stenosis as well as normal vessels. Therefore, it is…
2020 American Transplant Congress
Simultaneous Heart Kidney Transplant Benefits are Concentrated in the Dialysis Dependent Population
B. I. Shaw¹, M. L. Samoylova¹, Z. W. Fitch¹, M. Bishawi¹, R. Schmitz¹, S. J. Kesseli¹, A. S. Barbas¹, C. B. Patel², S. L. Sanoff², L. M. McElroy¹
¹Surgery, Duke University, Durham, NC, ²Medicine, Duke University, Durham, NC
*Purpose: With ongoing growth of simultaneous organ transplant and increased attention to allocation policy, we examined trends in simultaneous heart-kidney (SHK) transplantation outcomes over the…